CD19 and acute lymphoblastic leukemia: Fischer et al. (129) revealed that the total deletion (ex2-isoform) and partial deletion of exon 2 (ex2part-isoform) of CD19 in B cells, which cannot be recognized by CD19 CAR T-cells, existed in CD19+ B-ALL patients and healthy people before treatment.